they found significantly increased s-nitrosylated cdk5 (sno-cdk5) levels in postmortem human brain tissues of patients with ad compared to control brain tissue.
SNO-Cdk5 was not detectable in control human brains, thus indicating that measurable levels of SNO-Cdk5 are representative of a diseased state.